None listed
Conditions
Interventions
Medical Device : Participants will be randomly assigned to one of two groups, receiving a typical or an atypical form of moxibustion. They will receive a total of 8 sessions over the course of 4 weeks
Sponsors
Korea Institute of Oriental Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Males and females aged 20 to 65 (2) Diagnosed as Hwabyung based on a structure interview (SCID) for Hwabyung (3) Willingness to provide written informed consent.
Exclusion criteria
Exclusion criteria: (1) Seriously unstable medical condition (2) History or presence of severe mental diseases such as bipolar disorder or schizophrenia (3) Thyroid stimulating hormone level 1.5 times lower than the normal lower limit (4) Hemoglobin A1c =8 % (5) Medical treatment related to Hwa-byung within the last 2 weeks (6) Known hypersensitivity reactions or severe adverse events after moxibustion treatment, or an inability to receive moxibustion treatment by some reasons, especially difficulty in breathing (7) Pregnancy, breast-feeding, or women without proper contraception (8) Participants in other clinical trials (9) Residents of collective dwelling facilities such as social welfare institutions (10) Unwillingness to provide written informed consent (11) Participants judged unsuitable for the clinical trial by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hwa-byung symptom scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Korean-Beck Depression Inventory-II (K-BDI-II);Symptom CheckList-90-Revised (SCL-90-R);Instrument of pattern identification for Hwa-byung ;Recruitment rate, completion rate, and adherence | — |
Countries
Korea, Republic of
Contacts
Public ContactJoo Hee Kim
Korea Institute of Oriental Medicine
Outcome results
None listed